Alpha Tau Medical (DRTS) Competitors

Alpha Tau Medical (NASDAQ:DRTS) and BioLife Solutions (NASDAQ:BLFS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

Does the media refer more to DRTS or BLFS?

In the previous week, BioLife Solutions had 13 more articles in the media than Alpha Tau Medical. MarketBeat recorded 15 mentions for BioLife Solutions and 2 mentions for Alpha Tau Medical. Alpha Tau Medical's average media sentiment score of 0.83 beat BioLife Solutions' score of 0.42 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Tau Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BioLife Solutions	6 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is DRTS or BLFS more profitable?

Alpha Tau Medical has a net margin of 0.00% compared to BioLife Solutions' net margin of -5.39%. BioLife Solutions' return on equity of 0.16% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	-51.21%	-38.18%
BioLife Solutions	-5.39%	0.16%	0.14%

Do analysts prefer DRTS or BLFS?

Alpha Tau Medical currently has a consensus target price of $9.00, suggesting a potential upside of 129.53%. BioLife Solutions has a consensus target price of $31.29, suggesting a potential upside of 10.69%. Given Alpha Tau Medical's higher possible upside, equities analysts plainly believe Alpha Tau Medical is more favorable than BioLife Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
BioLife Solutions	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

Do institutionals and insiders hold more shares of DRTS or BLFS?

2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Comparatively, 2.2% of BioLife Solutions shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Which has more volatility & risk, DRTS or BLFS?

Alpha Tau Medical has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.95, suggesting that its stock price is 95% more volatile than the S&P 500.

Which has better earnings and valuation, DRTS or BLFS?

BioLife Solutions has higher revenue and earnings than Alpha Tau Medical. BioLife Solutions is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	-$31.75M	-$0.48	-8.17
BioLife Solutions	$82.25M	16.46	-$20.18M	-$0.12	-235.54

Summary

BioLife Solutions beats Alpha Tau Medical on 10 of the 15 factors compared between the two stocks.